Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia
Crossref DOI link: https://doi.org/10.1007/s40256-015-0150-3
Published Online: 2015-11-23
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Whayne, Thomas F. Jr.
Text and Data Mining valid from 2015-11-23
Article History
First Online: 23 November 2015
Compliance with Ethical Standards
:
: The author declares no conflicts of interest with respect to the research, authorship, and/or publication of this article.